Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Andrew Galler is an analyst at Morgan Stanley. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/20/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 03/07/2025 | IMCR | Buy Now | Immunocore Holdings | $28.71 | 21.91% | Andrew Galler33% | $35 → $35 | Assumes | → Equal-Weight | Get Alert |
| 12/13/2024 | IMCR | Buy Now | Immunocore Hldgs | $28.71 | 21.91% | Andrew Galler33% | $74 → $35 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 10/11/2024 | IMCR | Buy Now | Immunocore Hldgs | $28.71 | 157.75% | Andrew Galler33% | $80 → $74 | Maintains | Overweight | Get Alert |
| 11/09/2023 | FOLD | Buy Now | Amicus Therapeutics | $9.20 | 63.04% | Andrew Galler33% | $14 → $15 | Maintains | Equal-Weight | Get Alert |
| 10/10/2023 | FOLD | Buy Now | Amicus Therapeutics | $9.20 | 52.17% | Andrew Galler33% | $15 → $14 | Maintains | Equal-Weight | Get Alert |
| 08/01/2023 | IMCR | Buy Now | Immunocore Hldgs | $28.71 | 175.17% | Andrew Galler33% | $79 → $79 | Reiterates | Overweight → Overweight | Get Alert |
| 07/31/2023 | IMCR | Buy Now | Immunocore Hldgs | $28.71 | 175.17% | Andrew Galler33% | $79 → $79 | Reiterates | Overweight → Overweight | Get Alert |
| 07/24/2023 | IMCR | Buy Now | Immunocore Hldgs | $28.71 | 175.17% | Andrew Galler33% | $79 → $79 | Reiterates | Overweight → Overweight | Get Alert |
| 07/17/2023 | IMCR | Buy Now | Immunocore Hldgs | $28.71 | 175.17% | Andrew Galler33% | $79 → $79 | Reiterates | Overweight → Overweight | Get Alert |
| 07/11/2023 | IMCR | Buy Now | Immunocore Hldgs | $28.71 | 175.17% | Andrew Galler33% | $79 → $79 | Reiterates | Overweight → Overweight | Get Alert |
| 07/11/2023 | FOLD | Buy Now | Amicus Therapeutics | $9.20 | 63.04% | Andrew Galler33% | $15 → $15 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 06/26/2023 | IMCR | Buy Now | Immunocore Hldgs | $28.71 | 175.17% | Andrew Galler33% | $79 → $79 | Reiterates | Overweight → Overweight | Get Alert |
| 06/12/2023 | IMCR | Buy Now | Immunocore Hldgs | $28.71 | 175.17% | Andrew Galler33% | → $79 | Reiterates | → Overweight | Get Alert |
| 12/09/2022 | SLN | Buy Now | Silence Therapeutics | $3.78 | 376.19% | Andrew Galler33% | → $18 | Initiates | → Equal-Weight | Get Alert |
| 11/29/2022 | ARWR | Buy Now | Arrowhead Pharma | $15.47 | 139.17% | Andrew Galler33% | $41 → $37 | Maintains | Equal-Weight | Get Alert |
| 11/10/2022 | IONS | Buy Now | Ionis Pharmaceuticals | $33.34 | 67.97% | Andrew Galler33% | $57 → $56 | Maintains | Overweight | Get Alert |
| 11/10/2022 | IMCR | Buy Now | Immunocore Hldgs | $28.71 | 175.17% | Andrew Galler33% | $72 → $79 | Maintains | Overweight | Get Alert |
| 11/08/2022 | FOLD | Buy Now | Amicus Therapeutics | $9.20 | 63.04% | Andrew Galler33% | $14 → $15 | Maintains | Equal-Weight | Get Alert |
| 11/04/2022 | VIR | Buy Now | Vir Biotechnology | $6.95 | 158.99% | Andrew Galler33% | $15 → $18 | Maintains | Underweight | Get Alert |
| 10/13/2022 | IMCR | Buy Now | Immunocore Hldgs | $28.71 | 150.78% | Andrew Galler33% | $77 → $72 | Maintains | Overweight | Get Alert |
| 09/09/2022 | VIR | Buy Now | Vir Biotechnology | $6.95 | 115.83% | Andrew Galler33% | → $15 | Initiates | → Underweight | Get Alert |
| 09/09/2022 | PTCT | Buy Now | PTC Therapeutics | $56.00 | -3.57% | Andrew Galler33% | → $54 | Initiates | → Equal-Weight | Get Alert |
| 09/09/2022 | IMCR | Buy Now | Immunocore Hldgs | $28.71 | 168.2% | Andrew Galler33% | → $77 | Initiates | → Overweight | Get Alert |
| 09/09/2022 | IONS | Buy Now | Ionis Pharmaceuticals | $33.34 | 70.97% | Andrew Galler33% | $30 → $57 | Upgrade | Underweight → Overweight | Get Alert |
| 09/09/2022 | HALO | Buy Now | Halozyme Therapeutics | $64.55 | -22.54% | Andrew Galler33% | → $50 | Initiates | → Overweight | Get Alert |
| 09/09/2022 | ARWR | Buy Now | Arrowhead Pharma | $15.47 | 165.03% | Andrew Galler33% | → $41 | Initiates | → Equal-Weight | Get Alert |
| 09/09/2022 | FOLD | Buy Now | Amicus Therapeutics | $9.20 | 52.17% | Andrew Galler33% | → $14 | Initiates | → Equal-Weight | Get Alert |
| 11/09/2021 | MRNA | Buy Now | Moderna | $33.44 | 809.09% | Andrew Galler33% | → $304 | Initiates | → Outperform | Get Alert |
| 11/09/2021 | ADCT | Buy Now | ADC Therapeutics | $1.82 | 2317.58% | Andrew Galler33% | → $44 | Initiates | → Outperform | Get Alert |
